menu
    • menu

    Company profile for Annexon Biosciences

    NEW Drugs in Dev: 6
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our mission is to develop disease-modifying therapeutics for patients suffering with classical complement-mediated autoimmune, ophthalmic and neurodegenerative disorders. Backed by a team with deep experience in autoimmune and neurodegenerative diseases, our mission is to rapidly advance disease-modifying therapeutics for patients with complement-mediated autoimmune and neurodegenerative disorders. Annexon’s leadership has a...
    Our mission is to develop disease-modifying therapeutics for patients suffering with classical complement-mediated autoimmune, ophthalmic and neurodegenerative disorders. Backed by a team with deep experience in autoimmune and neurodegenerative diseases, our mission is to rapidly advance disease-modifying therapeutics for patients with complement-mediated autoimmune and neurodegenerative disorders. Annexon’s leadership has an extensive and successful track-record of discovering, developing and commercializing breakthrough therapeutics for debilitating disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Annexon BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    180 Kimball Way, 2nd Floor, Suite 200 South San Francisco, CA 94080
    Telephone
    Telephone
    650.822.5500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://annexonbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/annexon-biosciences
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    International Sweetener Colloquium

    Not Confirmed

    envelop Contact Supplier

    International Sweetener Colloquium

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Annexon Issues Inducement Grants To New Hires Per Nasdaq LR
    Annexon Issues Inducement Grants To New Hires Per Nasdaq LR

    16 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/16/3220575/0/en/Annexon-Reports-Inducement-Grants-to-New-Employees-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    16 Jan 2026
    Share Share
    Annexon Advances Immunotherapy For Neuroinflammatory Diseases
    Annexon Advances Immunotherapy For Neuroinflammatory Diseases

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3216698/0/en/Annexon-Accelerating-Next-Generation-Targeted-Immunotherapy-Platform-for-Treatment-of-Neuroinflammatory-Diseases-with-Multiple-Registrational-Milestones-in-2026.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    Annexon Seeks EMA Approval For Guillain-Barré Syndrome
    Annexon Seeks EMA Approval For Guillain-Barré Syndrome

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215336/0/en/Annexon-Submits-Tanruprubart-Marketing-Authorization-Application-to-the-European-Medicines-Agency-for-Guillain-Barr%C3%A9-Syndrome.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    Annexon Bio To Present At J.P. Morgan Healthcare Conference
    Annexon Bio To Present At J.P. Morgan Healthcare Conference

    07 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214900/0/en/Annexon-Biosciences-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    07 Jan 2026
    Share Share
    Annexon Grant Inducement To New Employee Per Nasdaq LR 5635(c)(4)
    Annexon Grant Inducement To New Employee Per Nasdaq LR 5635(c)(4)

    16 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/17/3206678/0/en/Annexon-Reports-Inducement-Grant-to-New-Employee-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    16 Dec 2025
    Share Share
    Annexon Completes Public Offering, Raises $86.25M
    Annexon Completes Public Offering, Raises $86.25M

    14 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/14/3188597/0/en/Annexon-Announces-Closing-of-Public-Offering-and-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares-for-Gross-Proceeds-of-86-25-Million.html

    GLOBENEWSWIRE
    14 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search